Achillion gets carbapenem compounds from FOB Synthesis
Deal Date: Apr-01-2008 / Deal # 200820214
Executive Summary
FOB Synthesis (uses synthetic organic and medicinal chemistry for drug discovery ) licensed Achillion Pharmaceuticals (infectious disease therapeutics) exclusive worldwide rights to develop and commercialize carbapenem compounds for bacterial infections.